Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02368210 · ClinicalTrials.gov registry record · Phase 3
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)
A Phase 3 study, sponsored by Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 151
- Enrollment target
NCT02368210 is a Phase 3 study that has completed, run by Therapeutics. The registered enrollment target is 151 participants.
The verdict
NCT02368210, a Phase 3 study, has completed, sponsored by Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 151 participants
- Enrollment target
Study Summary
This Phase 3 study (Study 306) has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.
Interventions
- DRUG Vehicle Foam
- DRUG 122-0551 Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02368210
The ClinicalTrials.gov registry entry for NCT02368210 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Therapeutics, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Foam is the first listed.
NCT02368210 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02368210 about?
NCT02368210 is a clinical study titled "A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)". This Phase 3 study (Study 306) has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.
What is the current status of trial NCT02368210?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 151 participants. The study started on 2015-01. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02368210?
The interventions under investigation include: Vehicle Foam (DRUG), 122-0551 Foam (DRUG).
Who is sponsoring clinical trial NCT02368210?
This trial is sponsored by Therapeutics, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.